South Korea · Series B startup

Who invested in Ybrain

3 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Medical Devices

Funding summaryUpdated 26 Oct 2026

$4.1Mraised across 3 rounds since 2013, from 3 sources

$643KRound$3.5MSeries A
Latest round
Series BAug 2015
Biggest round
$3.5MSeries A · Aug 2014
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201320142015
$643KRound$3.5MSeries A?Series B
First round
Round, $643K
Feb 2013
Biggest round
$3.5M
Series A · Aug 2014
Usual gap between rounds
18 months
the median of 2

The rounds

  1. Aug 2015
    Series BAmount undisclosed

    No investor was named in the report.

    From a historical funding record

  2. Aug 2014
    Series A$3.5M1 new

    From a historical funding record

  3. Feb 2013
    Round$643K

    No investor was named in the report.

    From a historical funding record

Everyone who backed them

Stonebridge CapitalPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Ybrain

Who invested in Ybrain?

Ybrain's investors include Stonebridge Capital.

How much has Ybrain raised?

Ybrain has raised $4.1M across 3 rounds since 2013. One round did not disclose an amount, so the total is a floor.

When did Ybrain last raise?

Ybrain's most recent round was a Series B in Aug 2015.

What was Ybrain's biggest round?

Ybrain's largest round on record is $3.5M (Series A), in Aug 2014.

Who backed Ybrain first?

Ybrain's first round on record, in Aug 2014, was backed by Stonebridge Capital.

What stage is Ybrain at?

Ybrain's latest named round is a Series B, in Aug 2015.

Where is Ybrain based?

Ybrain is based in South Korea.

Companies like Ybrain

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.